Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c \u2018hydrocortisone-polarised\u2019 macrophages

Yerel katalogda bu makaleye atıf yapan 19 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsAtıf 19 · OpenAlex
2. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsAtıf 19 · OpenAlex
3. 2024 Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cellsAtıf 19 · OpenAlex
4. 2025 Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 PathwayAtıf 9 · OpenAlex
5. 2025 Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 PathwayAtıf 8 · OpenAlex
6. 2025 Anti‐Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin‐1 PathwayAtıf 8 · OpenAlex
7. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Atıf 5 · OpenAlex
8. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Atıf 5 · OpenAlex
9. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Atıf 5 · OpenAlex
10. 2024 Enhanced angiogenesis of human umbilical vein endothelial cells via THP‐1‐derived M2c‐like macrophages and treatment with proteasome inhibitors ‘bortezomib and ixazomib’Atıf 5 · OpenAlex